Yumi Nagatsuka, C. Nakashima, N. Kitayama, Yoshio Ishida, Kenji Kabashima, Atsushi Otsuka
{"title":"一例单侧表皮痣并发特应性皮炎的病例,使用杜必鲁单抗进行治疗","authors":"Yumi Nagatsuka, C. Nakashima, N. Kitayama, Yoshio Ishida, Kenji Kabashima, Atsushi Otsuka","doi":"10.24294/ti.v8.i1.2773","DOIUrl":null,"url":null,"abstract":"Epidermal Nevus Syndrome (ENS) is a congenital disorder characterized by skin lesions called epidermal nevi. This condition typically appears at birth or in infancy. However, a case of adult‐onset epidermal nevi was reported in a 36‐year‐old male with a history of atopic dermatitis (AD) and skin abnormalities on the right side of his body. He had been using topical steroids for AD but eventually started dupilumab treatment at age 41. The treatment led to significant improvements in his skin condition, including a reduction in erythema and scaling. Laboratory tests also showed improvement in serum Immunoglobulin E (IgE) levels and other markers. We report with a literature review.","PeriodicalId":401129,"journal":{"name":"Trends in Immunotherapy","volume":"185 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A case of unilateral epidermal nevi complicated by atopic dermatitis treated with dupilumab\",\"authors\":\"Yumi Nagatsuka, C. Nakashima, N. Kitayama, Yoshio Ishida, Kenji Kabashima, Atsushi Otsuka\",\"doi\":\"10.24294/ti.v8.i1.2773\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Epidermal Nevus Syndrome (ENS) is a congenital disorder characterized by skin lesions called epidermal nevi. This condition typically appears at birth or in infancy. However, a case of adult‐onset epidermal nevi was reported in a 36‐year‐old male with a history of atopic dermatitis (AD) and skin abnormalities on the right side of his body. He had been using topical steroids for AD but eventually started dupilumab treatment at age 41. The treatment led to significant improvements in his skin condition, including a reduction in erythema and scaling. Laboratory tests also showed improvement in serum Immunoglobulin E (IgE) levels and other markers. We report with a literature review.\",\"PeriodicalId\":401129,\"journal\":{\"name\":\"Trends in Immunotherapy\",\"volume\":\"185 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Immunotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24294/ti.v8.i1.2773\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24294/ti.v8.i1.2773","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
表皮痣综合征(ENS)是一种先天性疾病,其特征是出现称为表皮痣的皮肤病变。这种疾病通常在出生时或婴儿期出现。然而,据报道,有一例成年后发病的表皮痣病例,患者是一名 36 岁的男性,有特应性皮炎(AD)病史,身体右侧皮肤异常。他曾使用外用类固醇药物治疗特应性皮炎,但最终在 41 岁时开始接受杜比单抗治疗。治疗后,他的皮肤状况有了明显改善,包括红斑和脱屑减少。实验室检测也显示血清免疫球蛋白 E (IgE) 水平和其他指标有所改善。我们通过文献综述进行了报告。
A case of unilateral epidermal nevi complicated by atopic dermatitis treated with dupilumab
Epidermal Nevus Syndrome (ENS) is a congenital disorder characterized by skin lesions called epidermal nevi. This condition typically appears at birth or in infancy. However, a case of adult‐onset epidermal nevi was reported in a 36‐year‐old male with a history of atopic dermatitis (AD) and skin abnormalities on the right side of his body. He had been using topical steroids for AD but eventually started dupilumab treatment at age 41. The treatment led to significant improvements in his skin condition, including a reduction in erythema and scaling. Laboratory tests also showed improvement in serum Immunoglobulin E (IgE) levels and other markers. We report with a literature review.